Infantile hemangioma
Death Associated With Nadolol for Infantile Hemangioma: A Case for Improving Safety
... making this therapy dangerous. b-adrenergic antagonist toxicity causes bradycardia, hypotension, hypoglycemia, and even death. We report a case of a 10-week-old girl who was started on nadolol for infantile ...
7
Original Article Role of endothelial-mesenchymal transition in the tumorigenesis of infantile hemangioma
... Infantile hemangioma (IH) is one of the most common benign tumors of infancy that occurs in 5% to 10% Caucasian infants. Most of the patients exhibit significant clinical symptoms withintwo years, with the ...
8
Hyperkalemia Complicating Propranolol Treatment of an Infantile Hemangioma
... cutaneous-subcutaneous hemangioma of the right lateral thoracic wall, which we treated suc- cessfully with ...of infantile hemangioma, close monitoring of serum electrolytes, besides the monitoring ...
7
Quality of life in children with infantile hemangioma: a case control study
... Background: Infantile hemangioma (IH) is the most common vascular tumor in children. It is controversial whether IHs has effects on the quality of life (QOL) in patients of whom IH poses no threat or ...
8
Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice
... Infantile hemangioma is a benign endothelial tumor composed of disorganized blood ...from hemangioma tissue that give rise to hemangioma-like lesions in immunodeficient ...the ...
9
Oral Propranolol: A Useful Treatment for Infantile Hemangioma
... Accidental discovery of accelerated involution of infantile hemangioma induced by propranolol has resulted in a recognized shift in the treatment of disfiguring proliferating infantile ...
10
Original Article The adipogenesis in infantile hemangioma and the expression of adipogenic-related genes
... Infantile hemangioma (IH), a common benign tumor in children, grows quickly in the six months to one year after birth, then regresses slowly in childhood, and is replaced by fibrofatty tissue finnaly ...
7
The Infantile Hemangioma Referral Score: A Validated Tool for Physicians
... POTENTIAL CONFLICT OF INTEREST: Dr Léauté-Labrèze is a consultant and clinical trial investigator for Pierre Fabre and is a member of the Infantile Hemangioma European Task Force (IHETF) and received ...
11
Cardiac arrest in a toddler treated with propranolol for infantile Hemangioma: a case report
... 1. Prey S, Voisard JJ, Delarue A, Lebbe G, Taieb A, Leaute-Labreze C, et al. Safety of Propranolol therapy for severe infantile Hemangioma. JAMA. 2016;315(4):413 – 5. 2. Hoeger PH, Harper JI, Baselga E, ...
5
Rebound of Involuted Infantile Hemangioma After Administration of Salbutamol
... of infantile hemangioma (IH), there has been emergent investigation of b-adrenergic receptor (b-AR) signaling in IH and the mechanisms of action for which b-AR blockers regulate hemangioma cell ...
5
Vectra 3D Imaging for Quantitative Volumetric Analysis of the Efficacy of Propranolol in Infantile Hemangioma
... Infantile hemangioma (IH) is a common tumor in infants. After the prolifer- ative phase, hemangiomas regress, but sometimes leave scars. Propranolol is now the recommended first-line oral therapy for IH. To ...
7
Endothelial and circulating C19MC microRNAs are biomarkers of infantile hemangioma
... Infantile hemangioma (IH) is a benign vascular tumor that proliferates rapidly after birth and then eventu- ally involutes, often being replaced by fibrofatty tissue ...
15
Continuous delivery of propranolol from liposomes-in-microspheres significantly inhibits infantile hemangioma growth
... of infantile hemangioma, we can safely conclude that needle injection into hemangioma does not induce bleeding even in big hemangiomas, and the slight bleeding that occurs can be easily suppressed by ...
14
Diagnosis and Management of Infantile Hemangioma: Executive Summary
... intervention or consequence. However, a subset of IHs may be associated with complications, resulting in pain, functional impairment, or permanent dis fi gurement. As a result, the primary care provider is often called on ...
8
β-adrenergic receptor-dependent and -independent effects of propranolol in infantile hemangioma
... Infantile hemangioma (IH) is the most common tumour of ...study. Hemangioma-derived stem cells and vascular endothelial cells were exposed to propranolol and were assayed for cellular and molecular ...
94
Burn Hemangioma (BH) (Scalded Pyogenic Granuloma) versus Infantile Hemangioma: Report of Six Cases of BH and Its Effective Therapy with Oral Propranolol
... DOI: 10.4236/jcdsa.2017.73022 234 J. Cosmetics, Dermatological Sciences and Applications proliferation of small capillaries, often arranged in a lobular pattern. Lesional capillaries are lined by flattened to slightly ...
17
Genomic Imprinting of IGF2 Is Maintained in Infantile Hemangioma despite its High Level of Expression
... Infantile hemangioma proliferates rapidly during the 1st year of the child’s life (proliferating phase), involutes slowly during the next 5 y (involuting phase), and regresses to fibrofatty tissue by 10 y ...
7
Safety of Oral Propranolol for Infantile Hemangioma
... WHAT’S KNOWN ON THIS SUBJECT: Oral propranolol was approved for the treatment of “proliferating infantile hemangioma requiring systemic treatment. ” A risk management plan was implemented, and the following ...
11
Role of propranolol in the management of infantile hemangioma
... for infantile hemangiomas was ...refractory hemangioma cases have other treatment modalities been considered, such as chemotherapeutic agents (vincristine, interferon-alpha), laser therapy, surgery or a ...
5
Original Article PDGFR-β (+) perivascular cells from infantile hemangioma display the features of mesenchymal stem cells and show stronger adipogenic potential in vitro and in vivo
... Abstract: Infantile hemangioma, a common benign tumor of infancy, grows quickly in the first year of life, and then regresses slowly to fibrofatty tissue in ...in hemangioma involution indicates ...
10